| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/07/2002 | WO2002009639A2 Methods and pharmaceutical compositions for healing wounds |
| 02/07/2002 | WO2001085700A3 Hiv replication inhibiting pyrimidines and triazines |
| 02/07/2002 | WO2001083439A3 Novel $g(y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. |
| 02/07/2002 | WO2001081310A8 1-aroyl-piperidinyl benzamidines |
| 02/07/2002 | WO2001078652A3 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/07/2002 | WO2001074380A3 Medicament containing a tissue inhibitor of metalloproteinases-2 (timp-2) as an osteo-anabolically active substance |
| 02/07/2002 | WO2001067890A3 Composition and method to treat weight gain and obesity attributable to psychotropic drugs |
| 02/07/2002 | WO2001066101A3 Treatment of psoriasis |
| 02/07/2002 | WO2001059127A3 Drug metabolizing enzymes |
| 02/07/2002 | WO2001058470A3 Methods for enhancing the bioavailability of a drug |
| 02/07/2002 | WO2001057193A3 Protein c derivatives |
| 02/07/2002 | WO2001056959B1 A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 02/07/2002 | WO2001053469A3 Phosphatases |
| 02/07/2002 | WO2001041747A3 Pharmaceutical preparation containing cytostatic agents and electron acceptors for treating cancer |
| 02/07/2002 | WO2001035935B1 Inhibitors of endo-exonuclease activity such as pentamidine for the treatment of cancer |
| 02/07/2002 | WO2001032831A3 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 02/07/2002 | WO2001030333A3 Tissue factor antagonists and methods of use thereof |
| 02/07/2002 | WO2001029255A9 Diagnostic test for cephalic pain |
| 02/07/2002 | WO2001024781A3 Gene necessary for striatal function, uses thereof, and compounds for modulating same |
| 02/07/2002 | WO2001017479B1 Methods and compositions for preventing and treating prostate disorders |
| 02/07/2002 | WO2001013900A3 Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 02/07/2002 | WO2001010425A3 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes |
| 02/07/2002 | WO2001000566A3 Substituted phenoxyacetic acids |
| 02/07/2002 | WO2000072015A3 Diagnostics and therapeutics for cardiovascular disorders |
| 02/07/2002 | WO2000071753A3 Diagnostics and therapeutics for restenosis |
| 02/07/2002 | WO2000060117A3 Prediction of risk of interstitial lung disease |
| 02/07/2002 | US20020016976 Mutant multi-substrate enzyme which accepts at least one orthogonal substrate analog, whereby catalytic activity results in combination of all or part of orthogonal substrate with other substrate of enzyme; drug screening |
| 02/07/2002 | US20020016625 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016362 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 02/07/2002 | US20020016360 Method of diminishing the adverse effects of interleukin-2 |
| 02/07/2002 | US20020016352 Cancer treatment with Go6976 and its related compounds |
| 02/07/2002 | US20020016348 Administering 5HT1B/1D agonist and COX-2 selective inhibitor |
| 02/07/2002 | US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha |
| 02/07/2002 | US20020016344 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| 02/07/2002 | US20020016342 Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/07/2002 | US20020016341 Heterocyclic thioester and ketone hair growth compositions and uses |
| 02/07/2002 | US20020016340 Compositions and methods for treating cataracts |
| 02/07/2002 | US20020016334 Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) |
| 02/07/2002 | US20020016331 Method of treating pain using nalbuphine and opioid antagonists |
| 02/07/2002 | US20020016328 Corticotropin releasing factor antagonists |
| 02/07/2002 | US20020016322 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use |
| 02/07/2002 | US20020016319 E.g., synergistic mixture of clonidine and memantine. |
| 02/07/2002 | US20020016303 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. |
| 02/07/2002 | US20020016301 Preventing or treating emesis associated with a macrolide antibiotic comprising administering a Substance P antagonist, such as (2S,3S)-3-(5-tert-butyl-2-methoxybenzyl)amino-2-(3 -trifluromethoxylphenyl)piperidine |
| 02/07/2002 | US20020016294 Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 02/07/2002 | US20020016293 Flavopiridol drug combinations and methods with reduced side effects |
| 02/07/2002 | US20020016284 Detecting or measuring the amount of oxidative stress or damage in a subject suspected of having Alzheimer's disease; screening, diagnosis, therapy |
| 02/07/2002 | US20020016283 Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist |
| 02/07/2002 | US20020015987 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects |
| 02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 02/07/2002 | US20020015957 Detecting in a biological sample from the subject an abnormal activity or an abnormal level of at least one complement pathway associated molecule, or an abnormal cellular activity mediated by the complement pathway |
| 02/07/2002 | US20020015742 For women; various concentrations |
| 02/07/2002 | US20020015740 Administering nitrogen oxide mimetic |
| 02/07/2002 | US20020015735 Oral administering |
| 02/07/2002 | US20020015728 Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 02/07/2002 | US20020015713 An amine containing compound such as the antidepressant dioxepin or the muscle relaxant guaifenesin and carriers |
| 02/07/2002 | US20020015704 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 02/07/2002 | US20020015703 Monoclonal antibodies or soluble immunoglobulin fusion proteins to block the development of chronic Graft-Versus-Host Disease |
| 02/07/2002 | US20020015701 Inhibiting properdin-induced stabilization of C3 convertase by exposure to an anti-properdin antibody |
| 02/07/2002 | DE10036051A1 Cosmetic or dermatological preparations for treating sun-tanning contain chitosan and lecithin to delay vaporization of volatile components |
| 02/07/2002 | DE10034607A1 Multispezifisches Reagenz zur selektiven Stimulierung von Zelloberflächenrezeptoren Multi-specific reagent for the selective stimulation of cell surface receptors |
| 02/07/2002 | CA2418120A1 High affinity integrin polypeptides and uses thereof |
| 02/07/2002 | CA2418115A1 Imidazole derivatives |
| 02/07/2002 | CA2418071A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis |
| 02/07/2002 | CA2417848A1 Compositions and methods for the treatment of anorectal disorders |
| 02/07/2002 | CA2417799A1 Inhibitors of cellular efflux pumps of microbes |
| 02/07/2002 | CA2417671A1 Trp8, trp9 and trp10, novel markers for cancer |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | CA2417636A1 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 02/07/2002 | CA2417627A1 Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs |
| 02/07/2002 | CA2417568A1 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | CA2417550A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 02/07/2002 | CA2417533A1 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 02/07/2002 | CA2417495A1 Methods for treating cell proliferative disorders and viral infections |
| 02/07/2002 | CA2417489A1 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| 02/07/2002 | CA2417359A1 Protein phosphatases |
| 02/07/2002 | CA2417336A1 Method for reducing exacerbations associated with copd |
| 02/07/2002 | CA2417304A1 Anticonvulsant derivatives useful for the treatment of depression |
| 02/07/2002 | CA2417254A1 N-¢5-¢¢¢5-alkyl-2-oxazolyl!methyl!thio!-2-thiazolyl! carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | CA2417195A1 G-protein coupled receptors |
| 02/07/2002 | CA2416978A1 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | CA2416824A1 Use of an arylaldehyde 5-oxo-1, 2, 4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | CA2416820A1 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | CA2416800A1 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 02/07/2002 | CA2416788A1 Methods and pharmaceutical compositions comprising protein kinase c isoforms for healing wounds |
| 02/07/2002 | CA2416152A1 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/07/2002 | CA2416137A1 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 02/07/2002 | CA2415826A1 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
| 02/07/2002 | CA2415789A1 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 02/07/2002 | CA2415473A1 Apo-2l receptor agonist and cpt-11 synergism |
| 02/07/2002 | CA2415078A1 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 02/07/2002 | CA2414623A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
| 02/07/2002 | CA2388550A1 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/06/2002 | EP1178115A2 Phosphodiesterase |
| 02/06/2002 | EP1178104A1 Use of essential oils for combatting GI tract infection by helicobacter-like organisms |
| 02/06/2002 | EP1177798A2 A pharmaceutical composition for the treatment of attention deficit hyperactivity disorder(ADHD) comprising a nicotine receptor partial agonist and anti-ADHD agent |
| 02/06/2002 | EP1177793A1 Inhalable medicinal aerosol composition for pain treatment or prevention |
| 02/06/2002 | EP1177791A2 Use of glycogen phosphorylase inhibitors to inhibit tumor growth |
| 02/06/2002 | EP1177787A2 Use of an estrogen agonist/antagonist for treating cataracts |